LeMaitre Vascular, Inc. (LMAT) CEO George LeMaitre on Q2 2022 Results - Earnings Call Transcript

SA Transcripts
153.96K Followers

Q2: 2022-07-28 Earnings Summary

EPS of $0.29 misses by $0.01
 | Revenue of $42.11M (3.54% Y/Y) beats by $716.62K

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q2 2022 Earnings Conference Call July 28, 2022 5:00 PM ET

Company Participants

J.J. Pellegrino - Chief Financial Officer
George LeMaitre - Chairman and Chief Executive Officer
David Roberts - President

Conference Call Participants

Zach Weiner - Jefferies
Brooks O’Neil - Lake Street Capital
Purnima Malik - Stifel
Matthew Mishan - KeyBanc
Michael Petusky - Barrington Research
Jim Sidoti - Sidoti & Company
Javier Fonseca - Spartan Capital

Operator

Welcome to the LeMaitre Vascular Q2 2022 Financial Results Conference Call. As a reminder, today's call is being recorded.

At this time, I would like to turn the call over to Mr. J.J. Pellegrino, Chief Financial Officer of LeMaitre Vascular. Please go ahead, sir.

A - J.J. Pellegrino

Thank you, operator. Good afternoon and thank you for joining us on our Q2 2022 conference call. With me on today's call are our Chairman and CEO, George LeMaitre; and our President, Dave Roberts.

Before we begin, I'll read our safe harbor statement. Today, we will make some forward-looking statements within the meaning of the US Private Securities Litigation Reform Act of 1995. The accuracy of which is subject to risks and uncertainties. Wherever possible, we will try to identify those forward-looking statements by using words such as believe, expect, anticipate, pursue, forecast and similar expressions. Our forward-looking statements are based on our estimates and assumptions as of today, July 28, 2022 and should not be relied upon as representing our estimates or views on any subsequent date. Please refer to the cautionary statement regarding forward-looking information and the risk factors in our most recent 10-K and subsequent SEC filings including disclosure of the factors that could cause results to differ materially from those expressed or implied.

During this call, we will discuss non-GAAP financial measures, which include organic sales growth, as

Recommended For You

About LMAT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on LMAT